A randomized, open-label, phase III trial comparing...

  • Main
  • 2016 / 11
  • A randomized, open-label, phase III trial comparing...
Annals of Oncology 2016 / 11

A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer

Yoshioka, H., Katakami, N., Okamoto, H., Iwamoto, Y., Seto, T., Takahashi, T., Sunaga, N., Kudoh, S., Chikamori, K., Harada, M., Tanaka, H., Saito, H., Saka, H., Takeda, K., Nogami, N., Masuda, N., Ha
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw621
Date:
November, 2016
File:
PDF, 572 KB
english, 2016
Conversion to is in progress
Conversion to is failed